tirzepatide cardiovascular outcomes trial 2024 reduces the predicted risk of atherosclerotic disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis - Hankosky - Tirzepatide linked to lower risk
Description
On availability, tirzepatide is what is actually in pharmacies
Track appetite changes subjectively on a 1-10 scale
About Mounjaro (Tirzepatide) Mounjaro is the brand name of an injectable tirzepatide medication that was developed to treat type 2 diabetes
A low responder achieving 12-15% weight loss over 12 months has succeeded in medical terms even if outcomes fall below population averages or personal hopes
Pharmacology studies have demonstrated that tirzepatide's effect on gastric emptying is most pronounced during the first few weeks of treatment and with dose escalations
A leading example of this type of therapy is Retatrutide, which is an entirely new type of peptide therapy
